Aleix Prat: Our new article about attitudes towards HER2DX in Spain

Aleix Prat, Director of the Cancer Institute at Hospital Clinic of Barcelona, shared on X/Twitter:

“Our new article is out, led by Olga Martínez-Sáez! Management of early-stage HER2+ breast cancer and attitudes towards HER2DX in Spain.

An online questionnaire was conducted by an independent third-party across 70 medical oncologists highly specialized in breast cancer in Spain. Conclusions:

• A notable diversity in therapeutic approaches was observed in the same clinical scenario
• The majority acknowledged HER2DX as a clinically valuable test for specific patients”

Further reading.
Source: Aleix Prat/X